Mischa J Kotlyar
Overview
Explore the profile of Mischa J Kotlyar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
3
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Choorapoikayil S, Kotlyar M, Kawohl L, Pratz P, Mehic D, Kranke P, et al.
BMC Anesthesiol
. 2025 Jan;
25(1):40.
PMID: 39863874
Background: Iron deficiency (ID) is the most common nutritional deficiency among patients undergoing major surgery. Treatment of ID is straightforward, however implementing a comprehensive anemia management strategy within clinical routines...
2.
Kotlyar M, Neef V, Rumpf F, Meybohm P, Zacharowski K, Kranke P
Anaesthesiologie
. 2024 Nov;
73(12):843-851.
PMID: 39542885
Postpartum hemorrhage (PPH) remains a leading cause of maternal mortality worldwide, with an increasing incidence in western countries over the past decades. During this period the numbers of PPH-related allogeneic...
3.
Krebs M, Kotlyar M, Fahl J, Janaki Raman S, Rohrig F, Marquardt A, et al.
Urol Int
. 2023 Nov;
108(1):49-59.
PMID: 38035560
Introduction: Metformin (MF) intake could be associated with a favorable outcome in sunitinib (SUT)- and axitinib (AX)-treated clear cell renal cell carcinoma (ccRCC) patients. Functionally, MF induces miR-205, a microRNA...
4.
Kotlyar M, Krebs M, Solimando A, Marquardt A, Burger M, Kubler H, et al.
Cancers (Basel)
. 2023 Apr;
15(7).
PMID: 37046643
(1) Background: Clear cell renal cell carcinoma extending into the inferior vena cava (ccRCC) represents a clinical high-risk setting. However, there is substantial heterogeneity within this patient subgroup regarding survival...